Log In
BCIQ
Print this Print this
 

LJPC-301

  Manage Alerts
Collapse Summary General Information
Company La Jolla Pharmaceutical Co.
DescriptionBiological galectin antagonist
Molecular Target
Mechanism of ActionGalectin antagonist
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today